REGENOCELL THERAPEUTICS, INC. Operating Expenses
REGENOCELL THERAPEUTICS, INC. reported Operating Expenses of $1.73 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. operating expenses for the quarter ending 2011-12-31 was $468.31K, a 84.74% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. operating expenses for the quarter ending 2011-09-30 was $478.00K, a 17.92% decline year-over-year.
- REGENOCELL THERAPEUTICS, INC. operating expenses for the quarter ending 2011-06-30 was $470.47K, a 128.15% increase year-over-year.
- REGENOCELL THERAPEUTICS, INC. operating expenses for the quarter ending 2010-12-31 was $3.07M.
- REGENOCELL THERAPEUTICS, INC. operating expenses for fiscal 2011 was $1.73M, a 61.30% decline from fiscal 2010.
- REGENOCELL THERAPEUTICS, INC. operating expenses for fiscal 2010 was $4.47M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2011-12-31 | $468.31K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $946.31K derived: sum of 2 quarters · filed 2012-05-25 | $1.42M derived: sum of 3 quarters · filed 2012-05-25 | $1.73M 10-K · filed 2012-05-25 |
| 2011-09-30 | $478.00K 10-Q · filed 2011-11-21 | $948.47K derived: sum of 2 quarters · filed 2011-11-21 | $1.26M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $470.47K 10-Q/A · filed 2011-09-01 | $781.58K 10-Q/A · filed 2011-09-01 | ||
| 2010-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $3.65M derived: sum of 2 quarters · filed 2012-05-25 | $3.86M derived: sum of 3 quarters · filed 2012-05-25 | $4.47M 10-K · filed 2012-05-25 |
| 2010-09-30 | $582.37K 10-Q · filed 2011-11-21 | $788.58K derived: sum of 2 quarters · filed 2011-11-21 | $1.40M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $206.21K 10-Q/A · filed 2011-09-01 | $799.50K 10-Q/A · filed 2011-09-01 |